Lab
First Quality Laboratory INC
First Quality Laboratory INC was paid $152K by Medicaid between Jan 2018 and Nov 2024, across 75 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 27% of everything it billed.
33Billing provider infoFIRST QUALITY LABORATORY INC
PEMBROKE PINES, FL 33029
PEMBROKE PINES, FL 33029
33aNPI1366513038assigned 11/13/2006
33bProvider typeClinical Medical Laboratory
28Total paid$152K
24GClaims265,828
24DCodes billed75
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#91 of 225
Median peer was paid$74K
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,309 | $7K | |
| 2019 | 61,767 | $18K | |
| 2020 | 53,245 | $30K | |
| 2021 | 44,254 | $60K | |
| 2022 | 34,671 | $24K | |
| 2023 | 16,552 | $8K | |
| 2024incomplete | 9,030 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 27% | 2,820 | 1,588 | $40K |
| 80053 | Comprehensive metabolic panel | 16% | 20,776 | 14,124 | $24K |
| 36415 | Collection of venous blood by venipuncture | 10% | 26,018 | 16,280 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8.2% | 10,390 | 7,311 | $12K |
| 80061 | Lipid panel | 4.3% | 17,401 | 12,419 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.1% | 14,944 | 10,597 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.1% | 27,703 | 17,891 | $6K |
| 87186 | 4.1% | 4,895 | 3,303 | $6K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 3.0% | 1,186 | 765 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.7% | 7,669 | 5,409 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 5,063 | 3,542 | $4K |
| 84439 | 1.8% | 2,689 | 1,841 | $3K |
63 more codes
| 84153 | 1.6% | 3,381 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.5% | 15,367 | $2K |
| 82607 | 1.2% | 7,195 | $2K | |
| 80164 | 1.1% | 1,132 | $2K | |
| 81001 | 1.0% | 9,786 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 695 | $1K |
| 83970 | <1% | 1,973 | $983.67 | |
| 84436 | <1% | 6,363 | $793.66 | |
| 82746 | <1% | 3,534 | $527.49 | |
| 86703 | <1% | 75 | $472.04 | |
| 84480 | <1% | 2,922 | $430.68 | |
| 84479 | <1% | 3,184 | $427.03 | |
| 85610 | <1% | 2,968 | $412.44 | |
| 87088 | <1% | 4,425 | $304.14 | |
| 81003 | <1% | 2,151 | $296.91 | |
| 84466 | <1% | 1,204 | $282.78 | |
| 82728 | <1% | 909 | $275.53 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 24,851 | $244.13 |
| 83540 | <1% | 2,803 | $195.10 | |
| 82570 | <1% | 2,393 | $190.06 | |
| 83735 | <1% | 2,604 | $185.93 | |
| 84550 | <1% | 3,825 | $179.35 | |
| 80076 | <1% | 1,098 | $171.49 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 55 | $166.88 |
| 82044 | <1% | 2,067 | $154.72 | |
| 87590 | <1% | 56 | $138.46 | |
| 84100 | <1% | 2,271 | $118.49 | |
| 82550 | <1% | 1,155 | $110.79 | |
| 85730 | <1% | 820 | $107.90 | |
| 85651 | <1% | 3,244 | $97.23 | |
| 86696 | <1% | 12 | $89.94 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 1,402 | $88.51 |
| 82140 | <1% | 41 | $85.60 | |
| 86140 | <1% | 1,967 | $83.19 | |
| 83721 | <1% | 812 | $78.12 | |
| 86803 | <1% | 13 | $63.64 | |
| 86695 | <1% | 12 | $60.78 | |
| 83090 | <1% | 880 | $56.15 | |
| 82378 | <1% | 110 | $51.02 | |
| 87340 | <1% | 61 | $49.91 | |
| 86592 | <1% | 74 | $35.92 | |
| 82274 | <1% | 98 | $20.78 | |
| 85049 | <1% | 1,283 | $20.36 | |
| 84481 | <1% | 403 | $20.34 | |
| 86141 | <1% | 244 | $17.37 | |
| 86038 | <1% | 95 | $9.11 | |
| 84156 | <1% | 1,065 | $7.18 | |
| 86430 | <1% | 88 | $4.01 | |
| 85046 | <1% | 268 | $3.65 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 187 | $0.00 |
| 82105 | 0% | 85 | $0.00 | |
| 83550 | 0% | 74 | $0.00 | |
| 84144 | 0% | 52 | $0.00 | |
| 82533 | 0% | 39 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 20 | $0.00 |
| 84134 | 0% | 112 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 25 | $0.00 |
| 82670 | 0% | 53 | $0.00 | |
| 83880 | 0% | 23 | $0.00 | |
| 84403 | 0% | 75 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 20 | $0.00 |
| 84681 | 0% | 37 | $0.00 | |
| 83525 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARCIA, MARIA (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Viatus, INC | El Paso, TX | $6.28M |
| Tree of Life Special Needs Adult Center LLC | Saint Cloud, FL | $2.64M |
| All Star Children's Care | Donna, TX | $1.38M |
| LA Buena Fe PHC Corporation | Brownsville, TX | $503K |
| Lahens Medical Center, INC. | Palmetto Bay, FL | $383K |
| LA Guardia Home Healthcare | El Paso, TX | $292K |
| JD Med Group, INC. | Juana Diaz, PR | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.